Interested Investigators
Since its inception in 1976, Ora’s drug development work has led to over 30 NDA approvals.
We are widely recognized as an innovator in the field of drug and device development because we do far more than simply conduct trials.
Ora maintains a high level of clinical excellence through our unique “Research on Research” approach, in which we continuously work alongside both sponsors and investigators to further optimize the design and implementation of our trials.
Our Experience
Ora has played an integral role in the development of many drug and device products in both the prescription and over-the-counter arenas:
Allergy Rx
- Patanol
- Emadine
- Livostin
- Alamast
- Alrex
- Alomide
- Elestat
- Pataday
Allergy OTC
- Visine A
- Vasocon–A
- Naphcon–A
- Opcon–A
- Alaway
- Zaditor
Inflammation Rx
- Volataren
- Acular
- TobraDex
- Lotemax
- Quixen
- Vexol
Dry Eye OTC
- Soothe
- Soothe XP
- Systane
- Systane Ultra
- Genteal
- Hypotear Line
- Visine Tear Line
- Refresh Tear Line
Glaucoma
- Alphagan
- Alphagan–P
- Lumigan
- Travatan
- Timoptic XE
- Trusopt
- Cosopt
- Combigan
Antibiotics
- Ocuflox
- Quixin
- AzaSite
- Iquix
- Vigamox
Ora's Innovation >